Mauduit C, Chauvin M A, de Peretti E, Morera A M, Benahmed M
INSERM CJF n. 90-08, Hôpital Sainte Eugénie, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.
Biol Reprod. 1991 Jul;45(1):101-9. doi: 10.1095/biolreprod45.1.101.
In the present study, we evaluated the effect of the homodimer activin A on immature porcine Leydig cell functions in primary culture. Activin A (0.5-100 ng/ml) reduced hCG-stimulated dehydroepiandrosterone (DHEA) accumulation in a dose- and time-dependent manner, with a maximal inhibitory effect (58% decrease) at 20 ng/ml (8 x 10(-10) M). Activin A was found not to control steroidogenesis, either through a modulation of the gonadotropin LH/hCG binding or low-density lipoprotein cholesterol binding and internalization. However, activin A significantly decreased pregnenolone (p less than 0.002) and DHEA (p less than 0.001) formation (evaluated in the presence of 10(-5) M of WIN 24540, an inhibitor of 3 beta-hydroxysteroid dehydrogenase/isomerase [3 beta-HSDI]activity) in Leydig cells maximally stimulated with hCG (3 ng/ml, 3 h) or incubated in the presence of 22R-hydroxycholesterol (5 micrograms/ml, 2 h). These findings indicate that activin A probably exerts a partial inhibitory effect on cholesterol side-chain cleavage cytochrome P450 (P450scc) activity. On the other hand, activin A significantly (p less than 0.001) enhanced the conversion of exogenous pregnenolone and DHEA (500 ng/ml) but not of progesterone and androstenedione (500 ng/ml) into testosterone, suggesting that activin A potentially enhances 3 beta-HSDI activity in Leydig cells. Activin A action on 3 beta-HSDI activity was found to be closely related to that of transforming growth factor-beta 1 (TGF beta 1), since both activin A (20 ng/ml) and TGF beta 1 (2 ng/ml) induced a comparable and non-additive increase in 3 beta-HSDI activity.(ABSTRACT TRUNCATED AT 250 WORDS)
在本研究中,我们评估了同型二聚体激活素A对原代培养的未成熟猪睾丸间质细胞功能的影响。激活素A(0.5 - 100 ng/ml)以剂量和时间依赖性方式降低了人绒毛膜促性腺激素(hCG)刺激的脱氢表雄酮(DHEA)积累,在20 ng/ml(8×10⁻¹⁰ M)时具有最大抑制作用(降低58%)。发现激活素A并非通过调节促性腺激素LH/hCG结合或低密度脂蛋白胆固醇结合及内化来控制类固醇生成。然而,激活素A显著降低了孕烯醇酮(p < 0.002)和DHEA(p < 0.001)的生成(在存在10⁻⁵ M的WIN 24540(一种3β - 羟基类固醇脱氢酶/异构酶[3β - HSDI]活性抑制剂)的情况下评估),该抑制作用在hCG(3 ng/ml,3小时)最大刺激的睾丸间质细胞中或在22R - 羟基胆固醇(5 μg/ml,2小时)存在下孵育的细胞中最为明显。这些发现表明激活素A可能对胆固醇侧链裂解细胞色素P450(P450scc)活性发挥部分抑制作用。另一方面,激活素A显著(p < 0.001)增强了外源性孕烯醇酮和DHEA(500 ng/ml)但非孕酮和雄烯二酮(500 ng/ml)向睾酮的转化,表明激活素A可能增强了睾丸间质细胞中的3β - HSDI活性。发现激活素A对3β - HSDI活性的作用与转化生长因子 - β1(TGFβ1)密切相关,因为激活素A(20 ng/ml)和TGFβ1(2 ng/ml)均诱导了3β - HSDI活性相当且无累加效应的增加。(摘要截短于250字)